Flagship Pioneering announced its newest company to emerge out of stealth mode today: Expedition Medicines. It is leveraging generative design for small molecule covalent chemistry
BiotechTV - News
00:00
High‑Throughput Proteomics Platform
Molly outlines their chemoproteomics engine that screens libraries across 20,000 proteome sites with dose responses.
Play episode from 03:57
Transcript
